Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases. The company was founded on April 25, 2019 and is headquartered in San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
53
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Third Harmonic Bio Inc market cap is $242.79M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Third Harmonic Bio Inc 52 week high is $16.02 as of November 19, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Third Harmonic Bio Inc 52 week low is $3.18 as of November 19, 2026.
Third Harmonic Bio Inc stock price today is $5.38.
Third Harmonic Bio Inc stock price yesterday was $5.39.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Third Harmonic Bio Inc's P/E ratio is -4.33.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Third Harmonic Bio Inc P/B ratio is 0.8872.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Third Harmonic Bio Inc 50-day moving average is $5.40.